Q3 2024 Suven Pharmaceuticals Ltd Earnings Call Transcript

Feb 05, 2024 / 01:00PM GMT
Operator

Ladies and gentlemen, good day and welcome to the Q3 FY '24 earnings conference call of Suven Pharmaceuticals Limited. Before we begin, I would like to state that some of the statements made in today's discussion may be forward-looking in nature and may involve risks and uncertainties. A detailed statement in this regard is available in the results presentation that was sent to you earlier. As a reminder, all participant lines will be in the listen-only mode.

There will be an opportunity for you to ask questions after the presentation concludes. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Ms. Cyndrella Carvalho, Head of Investor Relations from Suven Pharmaceuticals Limited. Thank you. Over to you, ma'am.

Cyndrella Carvalho - Suven Pharmaceuticals Limited - IR

Good evening, everyone, and a warm welcome to you all on Suven Pharma's Q3 FY '24 earnings call. Let me introduce you to our management team present here with us today: we have our Executive Chairman, Mr. Annaswamy Vaidheesh; our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot